MedPath

Effect of Written / Speech Expression on Depression, Anxiety and Stress

Not Applicable
Conditions
Coronary heart disease.
Coronary heart disease
Registration Number
IRCT20110219005866N29
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

No use of psychoactive drugs
No addiction

Exclusion Criteria

Patients for any reason continue to participate in the study at the time of study
Patients with less than three exposures in the emotional exacerbation group are excluded
Patients re-admitted to the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: Come to study, one week later, one month after the study. Method of measurement: DASS-21 questionnaire (depression, anxiety, stress).;Stress. Timepoint: Come to study, one week later, one month after the study. Method of measurement: DASS-21 questionnaire (depression, anxiety, stress).;Anxiety. Timepoint: Come to study, one week later, one month after the study. Method of measurement: DASS-21 questionnaire (depression, anxiety, stress).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath